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Effect of ATP-Sensitive Potassium Channel
Agonists on Ventricular Remodeling in Healed Rat Infarcts
Tsung-Ming Lee, MD, FESC,* Mei-Shu Lin, PHD,† Nen-Chung Chang, MD, PHD, FACC‡
Tainan and Taipei, Taiwan
Objectives The purpose of this study was to determine whether ATP-sensitive potassium (KATP) channel agonists exert a
beneficial effect on the structural, functional, and molecular features of the remodeling heart in infarcted rats.
Background Myocardial KATP channels have been implicated in the ventricular remodeling after myocardial infarction by inhi-
bition of 70-kDa S6 (p70S6) kinase.
Methods Male Wistar rats after induction of myocardial infarction were randomized to either vehicle, agonists of KATP
channels nicorandil and pinacidil, an antagonist of KATP channels glibenclamide, or a combination of nicorandil
and glibenclamide or pinacidil and glibenclamide for 4 weeks. To verify the role of p70S6 kinase in ventricular
remodeling, rapamycin was also assessed.
Results Significant ventricular hypertrophy was detected by increased myocyte size at the border zone isolated by enzy-
matic dissociation after infarction. Increased synthesis of p70S6 kinase messenger ribonucleic acid after infarc-
tion in vehicle-treated rats was confirmed by reverse transcription-polymerase chain reaction, consistent with the
results of immunohistochemistry and Western blot for phosphorylated p70S6 kinase. Rats in the nicorandil- and
pinacidil-treated groups significantly attenuated cardiomyocyte hypertrophy and phosphorylated p70S6 kinase
expression with similar potency, as compared with vehicle. The beneficial effects of nicorandil and pinacidil were
abolished by administering either glibenclamide or 5-hydroxydecanoate. Addition of rapamycin attenuated ven-
tricular remodeling and did not have additional beneficial effects compared with those seen in rats treated with
either nicorandil or pinacidil alone.
Conclusions Activation of KATP channels by either nicorandil or pinacidil can attenuate ventricular remodeling, probably
through a p70S6 kinase-dependent pathway after infarction. (J Am Coll Cardiol 2008;51:1309–18) © 2008 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.067c
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aardiac remodeling is an unfavorable evolution associated
ith myocardial hypertrophy after myocardial infarction
MI) (1). Cardiac remodeling is a complex process involving
umerous signaling pathways. Pharmacological therapies,
uch as angiotensin-converting enzyme inhibitors and beta-
lockers through different molecular targets, have been used
o improve cardiac remodeling (2). Previous studies have
hown that left ventricular (LV) remodeling is improved
fter nicorandil treatment (3), implying myocardial ATP-
ensitive potassium (KATP) channels may play a role in
entricular remodeling after infarction. We have shown a
irect relation between the activation of myocardial KATP
rom the *Cardiology Section, Department of Medicine, Taipei Medical University
nd Chi-Mei Medical Center, Tainan, Taiwan; †Department of Pharmacy, National
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Manuscript received June 7, 2007; revised manuscript received October 29, 2007,
ccepted November 19, 2007.hannels and ventricular remodeling by administering KATP
hannel antagonists in hyperlipidemic rabbits (4). Cabo and
oyden (5) have shown a marked reduction of the current
ensity of potassium current at the border zone cells
ompared with that in the remote sites. Activation of KATP
hannels has been shown to attenuate cardiac hypertrophy
y inhibition of 70-kDa S6 (p70S6) kinase (6), a key trigger
f protein synthesis for hypertrophic changes. The activity
f p70S6 kinase is controlled by multiple phosphorylation.
hosphorylation of Thr389 most closely correlates with
70S6 kinase activity in vivo (7). Although we have dem-
nstrated a cardioprotection against infarct of any size and
yocardial ischemia by activation of KATP channels in
nimals (8) and in humans (9) in acute settings, the
bserved beneficial effects do not provide information on
hether similar effects would be present on ventricular
emodeling with long-term administration of KATP channel
gonists.
Cardiac myocytes contain 2 distinct KATP channels with
subtype located in the sarcolemma and the other in the
w
o
a
d
v
5
K
M
A
l
i
i
o
(
p
p
M
c
b
6
m
c
n
(
s
c
v
r
c
r
e
l
w
w
m
t
d
t
i
m
2
s
p
a
d
c
t
g
w
c
c
a
s
k
K
a
h
n
n
p
c
N
e
C
a
m
3
5
K
a
W
e
l
t
E
m
r
p
p
a
w
a
E
l
m
w
t
1310 Lee et al. JACC Vol. 51, No. 13, 2008
KATP Channels and Ventricular Remodeling April 1, 2008:1309–18inner membrane of the mito-
chondria (10). Mitochondrial
KATP channels share some phar-
macological properties with sar-
colemmal KATP channels, while
possessing a distinct pharmaco-
logic response. KATP channels
are activated by numerous com-
pounds with distinct chemical
structures (11). These agents,
collectively termed as KATP
channel agonists, cause various
biological effects through modu-
lation of the sarcolemmal and
mitochondrial KATP channels
(11). Pinacidil has been shown to
activate both sarcolemmal and
mitochondrial KATP channels,
whereas nicorandil activates only
mitochondrial KATP channels
(11). The purpose of this study
as: 1) to investigate how 2 KATP channel agonists, nic-
randil and pinacidil, affect ventricular remodeling; 2) to
ssess the role of p70S6 kinase systems; and 3) to
etermine which subtype of KATP channels plays a role in
entricular remodeling in a rat MI model by the use of
-hydroxydecanoate (5-HD), a specific mitochondrial
ATP channel blocker.
ethods
nimals. Male Wistar rats (250 to 300 g) were subjected to
igation of the anterior descending artery, resulting in
nfarction of the LV free wall. Rats were randomly assigned
nto 9 groups so as to have approximately the same number
f survivors in each group: 1) vehicle group; 2) nicorandil
0.1 mg/kg/day, Chugai Pharmaceutical Co., Tokyo, Ja-
an), a specific mitochondrial KATP channel agonist; 3)
inacidil (0.1 mg/kg/day, Sigma Chemical Co., St. Louis,
issouri), a nonspecific KATP channel agonist; 4) gliben-
lamide (1.4 mg/kg/day), a nonspecific KATP channel
locker; 5) a combination of nicorandil and glibenclamide;
) a combination of pinacidil and glibenclamide; 7) rapa-
ycin (0.5 mg/kg/day), a p70S6 kinase inhibitor; 8) a
ombination of nicorandil and rapamycin; and 9) a combi-
ation of pinacidil and rapamycin. The doses of nicorandil
12), pinacidil (13), and glibenclamide (14) used in this
tudy have been shown to specifically modulate KATP
hannels without the interference of hemodynamics. To
erify the role of p70S6 kinase in KATP channel inhibition-
elated ventricular hypertrophy, we further assessed rapamy-
in in the role of ventricular remodeling. The oral dose of
apamycin was according to previous studies (6), showing
ffective attenuation of cardiac remodeling induced by
ong-term inhibition of nitric oxide synthesis. The drugs
Abbreviations
and Acronyms
GAPDH  glyceraldehyde-
3-phosphate-dehydrogenase
HD  hydroxydecanoate
KATP  ATP-sensitive
potassium
LV  left
ventricle/ventricular
LVEDD  left ventricular
end-diastolic diameter
dimension
LVESD  left ventricular
end-systolic diameter
dimension
MI  myocardial infarction
p70S6  70-kDa S6
RT-PCR  reverse
transcription-polymerase
chain reactionere given orally by gastric gavage once a day. The drugs Aere started 24 h after MI, during which drugs can
aximize benefits at this timing window (15) and minimize
he possibility of a direct effect on infarct size. The study
uration was designed to be 4 weeks because the majority of
he myocardial remodeling process in the rat (70% to 80%)
s complete within 3 weeks (16). To prevent hypoglyce-
ic attacks during the administration of glibenclamide,
.5% (weight/volume) sucrose in filtered tap water was
upplied and glucose examinations were performed once
er week by the 1-touch method. Sham operation served
s controls to exclude the possibility of drugs themselves
irectly to alter cardiomyocyte hypertrophy.
Although results of the above study showed that KATP
hannel antagonist-induced ventricular remodeling was al-
ered at 4 weeks after infarction (see Results section),
libenclamide was used as an antagonist of KATP channels,
hich can block both mitochondrial and sarcolemmal KATP
hannels and have multiple actions independent of KATP
hannels. To further confirm the role of KATP channel
gonist-induced ventricular remodeling and assess which
ubtype of KATP channels plays a role in attenuating p70S6
inase expression, we used 5-HD, a specific mitochondrial
ATP channel blocker, in an in vitro model. Four weeks
fter induction of MI by coronary ligation, infarcted rat
earts were isolated and subjected to no treatment (vehicle),
icorandil (50 M), pinacidil (50 M), 5-HD (100 M),
icorandil  5-HD, or pinacidil  5-HD. Each heart was
erfused with a noncirculating modified Tyrode’s solution
ontaining (in mM): NaCl 117.0, NaHCO3 23.0, KCl 4.6,
aH2PO4 0.8, MgCl2 1.0, CaCl2 2.0, and glucose 5.5,
quilibrated at 37°C and oxygenated with a 95% O2 to 5%
O2 gas mixture. The perfusion medium was maintained at
constant temperature of 37°C with a constant flow at 4
l/min as previously described (17). Drugs were infused for
0 min. The doses of nicorandil (18), pinacidil (19), and
-HD (20) used in this study have been shown to modulate
ATP channels in an isolated heart. At the end of the study,
ll hearts (n  10 in each group) were used for performing
estern blot from samples at the border zone. The animal
xperiment was approved and conducted in accordance with
ocal institutional guidelines for the care and use of labora-
ory animals in the Chi-Mei Medical Center.
xperimental MI. After anesthesia with ketamine (90
g/kg) intraperitoneally, rats were intubated and the ante-
ior descending artery was ligated using a 6-0 silk as
reviously described (17). Sham rats underwent the same
rocedure except the suture was passed under the coronary
rtery and then removed. Mortality in the animals with MI
as50% within the first 24 h. None of the sham-operated
nimals died.
chocardiogram. At 28 days after operation, rats were
ightly anesthetized with intraperitoneal injection of keta-
ine HCl (25 mg/kg). Echocardiographic measurements
ere done with an HP Sonos 5500 system with a 15-6L (6
o 15 MHz, SONOS 5500, Agilent Technologies, Palo
lto, California) probe. M-mode tracing of the LV was
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April 1, 2008:1309–18 KATP Channels and Ventricular Remodelingbtained from the parasternal long-axis view to measure left
entricular end-diastolic diameter dimension (LVEDD)
nd left ventricular end-systolic diameter dimension
LVESD), and fractional shortening (%) was calculated.
fter this, the hearts quickly underwent hemodynamic
easurement after systemic heparinization.
emodynamics and infarct size measurements. Using a
-F micromanometer-tipped catheter (Model SPR-407,
illar Instruments, Houston, Texas) inserted through the
ight carotid artery as in our previous description (17), we
easured the maximal rate of LV pressure rise (dP/dt)
nd decrease (dP/dt). Next, the heart was rapidly excised
nd divided into right and left atria, right ventricles,
V, and the scarred area. Each tissue was then weighed
ndividually. Infarct size (%) was expressed as the ratio of
he sum of external and internal perimeters of LV as
escribed by Pfeffer and Braunwald (16). Samples of the
V from the border zone (0 to 2 mm outside the infarct)
ere cut transmurally, frozen rapidly in liquid nitrogen,
nd stored at 80°C until use. It has been shown that
ypertrophy of the residual myocardium progresses after
I if infarct size is larger than 30% of the LV (16). Thus,
ith respect to clinical importance, only rats with infarc-
ion larger than 30% of the LV were selected for analysis.
everse transcription-polymerase chain reaction (RT-
CR) analysis of p70S6 kinase. To further confirm the
ownstream activation of KATP channels, messenger ribo-
ucleic acid (mRNA) levels of p70S6 kinase were measured
y real-time quantitative RT-PCR from samples obtained
rom the border zone with the TaqMan system (Prism
700 Sequence Detection System, Applied Biosystems,
ourtaboeuf, France) as in our previous description
17). For p70S6 kinase the primers were sense, 5=-
AAGATTTATTGGTAGCCCACGAA-3=; antisense, 5=-
CACCTCGTCCCCAGAAA-3=. For glyceraldehyde-3-
hosphate-dehydrogenase (GAPDH), the primers were
-CTTCACCACCATGGAGAAGGC-3= and 5=-
GCATGGACTGTGGTCATGAG-3=. For quantifica-
ion, p70S6 kinase expression was normalized to the ex-
ressed housekeeping gene GAPDH. Reaction conditions
ere programmed on a computer linked to the detector for
0 cycles of the amplification step.
estern blot analysis of p70S6 kinase. Samples from the
order zone were homogenized, and the supernatant protein
oncentration was determined with the BCA protein assay
eagent kit (Pierce, Rockford, Illinois); 20 g protein was
eparated by 8% SDS-PAGE and electrotransferred onto a
itrocellulose membrane. After incubation with anti–
hospho-p70S6 kinase antibodies (Thr389, #9205L, Cell
ignalling, Hitchin, Kent, United Kingdom) and anti–
otal-p70S6 kinase antibodies (#9202, Cell Signalling,
itchin), antigen-antibody complexes were detected with
-bromo-4-chloro-3-indolyl-phosphate and nitroblue
etrazolium chloride (Sigma). Films were volume-
ntegrated within the linear range of the exposure using a ccanning densitometer. Experiments were replicated 3
imes and results expressed as the mean value.
mmunohistochemical analysis of p70S6 kinase. To con-
rm the downstream pathways of KATP channel, immuno-
istochemical staining of phospho-p70S6 kinase was per-
ormed on LV muscle from the border zone. Cryosections
ere performed at a thickness of 5 m and incubated with
rabbit polyclonal anti–phospho-p70S6 kinase antibody
Santa Cruz Biotechnology, Santa Cruz, California) at
ilution 1:10. Immunostaining with p70S6 kinase antibod-
es was performed using a standard immunoperoxidase
echnique (N-Histofine Simple Stain Rat MAX PO kit,
ichirei Co., Tokyo, Japan). The antibody used had been
ested for specificity in the rat. Isotype-identical directly
onjugated antibodies served as a negative control.
ell isolation. Because cardiac hypertrophy is a combina-
ion of reactive fibrosis and myocyte hypertrophy, we
easured cardiomyocyte sizes at the border zone besides
sing myocardial weight to avoid the interference of non-
yocytes on post-infarction hypertrophy. Myocytes were
nzymatically isolated with collagenase (type II, Sigma) and
rotease (type XIV, Sigma) according to previously de-
cribed techniques (17). Random high-power fields of the
od-like relaxed myocytes with clear striations were selected
o eliminate selection bias. In the sham-operated group, cell
idth and length were measured from the LV free wall for
omparisons. At least 100 cells from each section were
elected for measurement of cell length, width, and area,
nd the mean value was used as the individual value for each
ection.
orphometric determination of cardiac fibrosis. Heart
ections from the remote regions were stained with Sirius
ed stain to distinguish areas of connective tissue as previ-
usly described (21). The percentage of red staining, indic-
tive of fibrosis, was measured in 10 fields randomly selected
n each section (Image Pro Plus, Media Cybernetics, Silver
pring, Maryland). The value was expressed as the ratio of
irius red-stained fibrosis area to total infarct area. All
ections were evaluated under blind conditions without
rior knowledge as to which section belonged to which rat.
aboratory measurements. To determine the confound-
ng roles of glucose and insulin in ventricular remodeling,
lood samples from the aorta were assayed at the end of the
tudy. Plasma insulin was measured by ultrasensitive rat
nzyme immunoassay (Mercodia, Uppsala, Sweden).
tatistical analysis. Results were presented as mean 
tandard deviation. Statistical analysis was performed using
he SPSS statistical package (version 10.0, SPSS Inc.,
hicago, Illinois). A 1-way analysis of variance was used to
earch for possible effects of nicorandil, pinacidil, and
libenclamide on the measurements of hemodynamics and
yocyte sizes. In case of a significant effect, the measure-
ents between the groups were compared, with a value of
 0.007 (Bonferroni’s correction) as significant. Proba-
ility values were 2-tailed, and a value of p  0.05 was
onsidered to be statistically significant.
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ifferences in mortality between vehicle (n  3, 25%) and
reated groups (n  20, 20%) were not found throughout
he study. No sham-operated rats had evidence of cardiac
amage. Blood pressure, heart rate, infarct size, and glucose
evels did not significantly differ among the infarcted groups
Table 1). Insulin concentrations were significantly in-
reased in rats that were administered glibenclamide.
orphometric studies. In the sham-operated rats, treat-
ent with either nicorandil, pinacidil, or glibenclamide had
ittle effect on cardiac gross morphology (data not shown),
hereas there were significant effects on the cardiac mor-
hology after MI (Table 1). Four weeks after MI, the
nfarcted area of the LV was very thin and was totally
eplaced by fully differentiated scar tissue. The vehicle-,
libenclamide-, and a combination of nicorandil and
libenclamide- or pinacidil- and glibenclamide-treated
roups had an increase in right ventricular weight/body
eight ratio, and lung weight/body weight ratio compared
ith the sham-operated rats.
To characterize the cardiac hypertrophy on a cellular
evel, we isolated cardiomyocytes from different treated
roups (Table 2). The cell areas isolated from the border
one in the vehicle significantly increased by 63% compared
ith those from the same area of sham-operated hearts
4,664  187 m2 in the vehicle vs. 2,863  92 m2, p 
.0001). Nicorandil and pinacidil reduced cell areas 20%
nd 19% compared with vehicle (both p  0.0001, respec-
ively). Conversely, the rats to which glibenclamide was
dministered developed cardiomyocyte hypertrophy com-
ared with the nicorandil- and pinacidil-treated groups
lone. Besides, treatment of rapamycin significantly atten-
ated cardiomyocyte hypertrophy and blunted the increase
n cell area by about 15% compared with those treated
ith vehicle at the border zone, a figure similar to that
n either the nicorandil- or pinacidil-treated group. How-
ver, addition of rapamycin did not further attenuate ven-
ricular hypertrophy in either the nicorandil- or pinacidil-
reated group.
Fibrosis of the LV from the remote zone was examined in
issue sections after Sirius red staining as shown in Figure 1.
nfarcted rats treated with vehicle had significantly larger
reas of intense focal fibrosis compared with sham-operated
ats (0.09  0.04% vs. 0.02  0.02%, p  0.0001).
ompared with vehicle, treatment with either nicorandil or
inacidil attenuated fibrosis. Collagen formation in the LV
as significantly increased in rats treated with a combina-
ion of KATP channel agonists and glibenclamide compared
ith KATP channel agonists-treated rats alone.
chocardiographic data. Compared with sham-operated
earts, MI hearts showed structural changes such as in-
reased LV diastolic and systolic diameters (Figs. 2 and 3),
onsistent with LV remodeling. Both LVEDD and
VESD in rats with MI were significantly reduced by
icorandil or pinacidil treatment (p  0.0001). Left ven- Ca T N B H L L L R L   I
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Characteristics of Isolated Cardiomyocytes
Table 2 Characteristics of Isolated Cardiomyocytes
Parameters Sham Vehicle Nic Rap Rap  Nic Rap  Pin
Number of animals 5 4 5 5 5 5
Border zone
Myocyte length, m 132 5 179 11* 158 8*† 161 11*§ 156 14*§ 153 9*§
Myocyte width, m 21 3 24 3* 21 2† 21 3§ 22 2§ 21 3§
Measured myocyte areas, m2 2,863 92 4,664 187* 3,721 153*† ,963 186*§ 3,894 132*§ 3,595 126*§
Remote zone
Myocyte length, m 135 6 143 13 141 10 145 11 138 11 143 11
Myocyte width, m 20 2 19 2 19 3 19 2 20 3 19 2
Measured myocyte areas, m2 2,861 97 2,959 89 2,985 102 ,008 114 2,983 86 3,197 105
Values aremean standard deviation. *p 0.005 compared with the sham-operated group; †p 0.007 co ted groups treated with vehicle and Pin Glib; §p 0.05 compared
with vehicle; p  0.05 compared with respective data from border zones within the same group.
Abbreviations as in Table 1.
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KATP Channels and Ventricular Remodeling April 1, 2008:1309–18ricular fractional shortening was significantly higher in the
icorandil- or pinacidil-treated group compared with the
ehicle. Conversely, the rats to which glibenclamide was
dministered developed impaired LV systolic function and
rogressive LV dilation more than that in the nicorandil-
nd pinacidil-treated groups alone. These data were corrob-
rated by the results that dP/dt and dP/dt were signif-
cantly improved in the nicorandil- and pinacidil-treated
Figure 2 Echocardiogram in Infarcted Rats
Representative M-mode image reveals a hypokinetic-to-akinetic anterior wall
and left ventricular (LV) dilation in the infarcted hearts (B to J) in contrast to
normal anterior wall motion in sham-operated heart (A). There are markedly
dilated LV end-diastolic diameter and LV end-systolic diameter in groups
treated with vehicle (B), Glib (E), Nic  Glib (F), and Pin  Glib (G) compared
with those in groups treated with Nic (C) and Pin (D). Besides, infarcted rats
treated with Rap (H), Rap  Nic (I), and Rap  Pin (J) showed a significant
decrease of LV end-diastolic diameter and LV end-systolic diameter compared
with vehicle. IVS  interventricular septum thickness; other abbreviations as in
Figure 1.roups compared with the combined groups.mmunohistochemical analyses, Western blot, and real-
ime PCR of p70S6 kinase. Immunohistochemical analy-
is of the infarcted myocardium revealed the presence of
hospho-p70S6 kinase immunoreactivity in the myocardial
issue (Fig. 4). Stronger phospho-p70S6 kinase signals at
he border zone of vehicle-treated rats were observed than in
he same region of sham rats. The intensity of the immu-
Figure 3 Comparison of LV Remodeling
and Function by 2D Echocardiography Study
Values are mean  standard deviation. p  0.005 compared with the sham
group; †p  0.007 compared with infarcted groups treated with vehicle and
Nic  Glib; ‡p  0.007 compared with infarcted groups treated with vehicle
and Pin  Glib; §p  0.007 compared with vehicle. LV  left ventricular; 2D 
2-dimensional; other abbreviations as in Figure 1.
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April 1, 2008:1309–18 KATP Channels and Ventricular Remodelingoreaction was reduced in the nicorandil- and pinacidil-
reated groups compared with that in the vehicle.
icorandil- and pinacidil-induced beneficial effects were
eversed by the addition of glibenclamide, implicating KATP
hannels as the relevant target.
Western blot shows that the levels of LV phospho-p70S6
inase were significantly more up-regulated 1.9-fold at the
order zone in the vehicle than in sham-operated rats (p 
.0001), whereas total p70S6 kinase remained constant
Fig. 5). Compared with vehicle in nicorandil- and
inacidil-treated rats, LV phospho-p70S6 kinase levels were
ignificantly lower at the border zone. The rats to which
libenclamide was administered showed significantly higher
hospho-p70S6 kinase levels than those in the nicorandil-
Figure 4 Immunohistochemical Microscopy of
p70S6 Kinase at the BZ in Different Treated Rats
Positive staining for phospho-p70S6 kinase (p70S6 kinase) (magnification
200) (brown color) in myocytes is significantly higher in groups treated with
vehicle (B), glibenclamide (E), and a combination of nicorandil  gliben-
clamide (F) and pinacidil  glibenclamide (G) than those in sham (A), nic-
orandil- (C), pinacidil- (D), rapamycin- (H), rapamycin  nicorandil- (I), and
rapamycin  pinacidil–treated rats (J). The line length corresponds to 200
m. BZ  border zone.nd pinacidil-treated groups alone. To elucidate the role ofitochondrial KATP channels in modulating p70S6 kinase,
-HD was assessed in an in vitro model. Figure 6 shows
hat 5-HD significantly inhibited attenuated expression of
hospho-p70S6 kinase compared with either nicorandil or
inacidil alone, confirming the role of mitochondrial KATP
hannels in mediating p70S6 kinase.
The mRNA levels of p70S6 kinase showed a 5.4 
.2-fold up-regulation at the border zone in the vehicle
ompared with the sham-operated rats (p  0.0001)
Fig. 7). Thus, the mRNA levels of p70S6 kinase changed
n parallel to the tissue peptide levels, implying that the
roduction of p70S6 kinase mRNA is a critical regulation
tep for its local activation.
iscussion
his study demonstrates for the first time that chronic
reatment for 4 weeks with KATP channel agonists leads to
avorable ventricular remodeling, probably through attenu-
ted activity of phospho-p70S6 kinase. These results were
oncordant for beneficial effects of KATP channel agonists,
s documented structurally by reduction in myocyte sizes
nd cardiac fibrosis, molecularly, by myocardial p70S6
inase protein and mRNA levels, and functionally, by
Figure 5 Western Blot of Phospo-p70S6 Kinase
and Total p70S6 Kinase in an In Vivo Study
(Top) Western blot analysis of p70S6 kinase showing the effect of KATP chan-
nels on immunorecognition of p70S6 kinase in homogenates of the LV from
the border zone. p70S6 kinase activity was measured with phospho-specific
antibody against phosphorylated p70S6 kinase (top band) and a total p70S6
kinase antibody (bottom band). Ventricular remodeling after myocardial infarc-
tion was associated with marked increase of phospho-p70S6 kinase. A signifi-
cantly reduced phospho-p70S6 kinase had taken place in the groups treated
with either nicorandil or pinacidil administration compared with that seen in
vehicle. (Bottom) Densitometric quantification of phosphorylation levels was
expressed as the ratio of the density of phosphorylated band over total p70S6
kinase. Each point is an average of 3 separate experiments. p  0.007 com-
pared with vehicle-, Glib-, Nic  Glib-, and Pin  Glib–treated groups. Abbrevia-
tions as in Figure 1.
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KATP Channels and Ventricular Remodeling April 1, 2008:1309–18mprovement of echocardiography-derived systolic function.
hese new observations strengthen the concept that KATP
hannels play a central role in the remodeling process and
ay improve our understanding of the beneficial effect of
arly administration of KATP channel agonists in post-
nfarction remodeling.
The beneficial effect of KATP channels on LV remodeling
as demonstrated as evidenced by 3 observations.
irst, KATP channel-related LV remodeling was noted after
nfarction. Administration of KATP channel agonists atten-
ates the dysfunction of chronically infarcted hearts. Car-
iomyocyte sizes, cardiac fibrosis, and echocardiographically
erived LVESD and LVEDD were significantly smaller in
ither the pinacidil- or nicorandil-treated group than those
n the vehicle. Our results were consistent with the findings
f Coromilas et al. (22), showing that KATP channels at the
order zone remain functional and can be activated by KATP
hannel agonists. The involvement of KATP channels is
urther supported by the antagonizing action of gliben-
lamide. Second, either pinacidil or nicorandil administra-
ion can attenuate cardiomyocyte hypertrophy with a similar
otency at the border zone. A similar potency to attenuate
ypertrophy by pinacidil and nicorandil may suggest that
Figure 6 Western Blot of Phospo-p70S6 Kinase
and Total p70S6 Kinase in an In Vitro Study
(Top) Western blot analysis of p70S6 kinase to furthermore confirm the mito-
chondrial KATP channels on p70S6 kinase activity in homogenates of the left
ventricle from the border zone in a rat isolated heart model. P70S6 kinase
activity was measured with phospho-specific antibody against phosphorylated
p70S6 kinase (top band) and a total p70S6 kinase antibody (bottom
band). A significantly increased phospho-p70S6 kinase is noted in the
groups treated with a combination of KATP channel agonists and 5-hydroxy-
decanoate (5-HD) compared with that seen in the groups treated with KATP
channel agonists alone. (Bottom) Densitometric quantification of phosphor-
ylation levels was expressed as the ratio of the density of phosphorylated
band over total p70S6 kinase. Each point is an average of 3 separate
experiments. p  0.007 compared with vehicle-, 5-HD-, Nic  5-HD-, and
Pin  5-HD–treated groups. Abbreviations as in Figure 1.itochondrial KATP channels play a role in regulatingardiomyocyte hypertrophy. Although dissimilar structures,
inacidil and nicorandil appear to share a common media-
or, p70S6 kinase, in which transcription levels of p70S6
inase may play a role in the signal transduction pathway.
hird, the involvement of p70S6 kinase in mitochondrial
ATP channel inhibition-related ventricular remodeling af-
er infarction was further confirmed by administering a
itochondrial KATP antagonist (5-HD). The pharmaco-
ogic selectivity of the used mitochondrial KATP channel
locker, at the conventional inhibitory concentrations (20)
sed in the present study may indicate the important role
f the mitochondrial KATP channel in modulating p70S6
inase activity, leading to attenuate cardiac hypertrophy.
urthermore, addition of rapamycin attenuated ventric-
lar remodeling and did not have additional beneficial
ffects compared with rats treated with either nicorandil
r pinacidil alone, confirming the critical role of p70S6
inase in ventricular remodeling. Indeed, our results were
onsistent with the observation that cell hypertrophy is
egulated by mitochondrial KATP channel-dependent
70S6 kinase (23,24).
It appears from our study that the attenuated ventricular
emodeling is related to an activation of KATP channels.
he mechanisms by which KATP channel agonists attenuate
entricular remodeling remain to be defined. However,
everal factors can be excluded: 1) hemodynamics: neither
inacidil nor nicorandil exerted any hemodynamic effects at
he dose used in this study. Nicorandil has been shown to
educe hypertrophy in animals, which has been assumed to
e due to the drug’s blood-pressure-lowering effect (25).
he observation was not consistent with our stable hemo-
ynamics throughout the study in nicorandil-treated rats.
ndeed, in rats, Xu et al. (26) have shown that oral dose of
icorandil (6 mg/kg/day), a dose much higher than that
Figure 7 Western Blot of p70S6 Kinase in an In Vivo Study
Each mRNA was corrected for an mRNA level of glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH). Each column and bar represents mean  standard
deviation. p  0.007 compared with vehicle-, Glib-, Nic  Glib-, and Pin 
Glib–treated groups. LV  left ventricular; other abbreviations as in Figure 1.
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April 1, 2008:1309–18 KATP Channels and Ventricular Remodelingsed in our study (0.1 mg/kg/day), did not lower blood
ressure. 2) Differences in MI size: MI size is an important
eterminant of LV remodeling (27). However, there is a
imilar MI size among the infarcted groups.
ther mechanisms. Although the present study suggests
hat the mechanisms of KATP channel agonist-induced
ttenuated ventricular remodeling may be related to inhibi-
ion of p70S6 kinase, there are possible other candidates
odulating the antihypertrophic effects of KATP channel
gonists, such as endothelin-1 and angiotensin. First, block-
de of endothelin-1 alleviated the development of cardiac
ypertrophy (28). Activation of KATP channels has been
hown to attenuate cardiac hypertrophy by inhibition of
ndothelin-1 (29). Thus, KATP channel agonists may atten-
ate cardiac hypertrophy by attenuated production of
ndothelin-1. Second, blunting by KATP channel agonists of
ntihypertropic effect may also result from attenuated effects
f angiotensin; KATP channel agonists have been shown to
nhibit angiotensin II-induced increase in cell protein con-
ent (30). Complex interactions between endothelin-1, an-
iotensin II, and KATP channels exist that could affect
ardiac hypertrophy. Therefore, a variety of upstream reg-
lators could interfere with hypertrophic signaling path-
ays. The development of cardiac hypertrophy is a multi-
enic, integrative response involving signal integration of
ultiple pathways. The failure to completely abrogate the
ypertrophic process was not surprising in view of the
nderlying complex of hypertrophic process, which is un-
ikely to be amendable to one therapeutic intervention.
linical implications. After acute MI, patients remain at
igh risk for recurrent cardiovascular events and mortality
31). Previous studies have demonstrated that regional
yocyte hypertrophy parallels regional myocardial dysfunc-
ion during post-infarct remodeling (32). Attenuation of
entricular remodeling prevents the transition for compen-
atory dilation to ventricular dysfunction and failure. Thus,
he KATP channel agonists may have important biological
ffects that prevent occurrence of post-infarcted heart fail-
re. Our results explained, at least in part, the clinical
ndings of the IONA (Impact Of Nicorandil in Angina)
tudy group (33), showing that treatment with nicorandil
mproves outcome in terms of reducing events related to
cute coronary disease and the associated requirement for
dmission to hospital.
onclusions
hese findings are consistent with a pathogenetic role of
egional KATP channels in cardiac remodeling after MI.
arly intervention with KATP channel agonists after MI can
ttenuate ventricular remodeling probably through inhibi-
ion of phospho-p70S6 kinase pathway. The pharmacologic
rofile of KATP channel agonists gives new perspectives in
he early treatment of acute MI.eprint requests and correspondence: Prof. Nen-Chung Chang,
ardiology Section, Department of Medicine, Taipei Medical
niversity and Hospital, 252, Wu-Hsing Street, Taipei, 110,
aiwan. E-mail: ncchang@tmu.edu.tw.
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